Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients

Frontiers Pyrotinib in the Treatment of Women With HER2-Positive

Emerging approaches for treating HER2-positive metastatic breast

TCHP-Docetaxel Carboplatin Trastuzumab Pertuzumab Neoadjuvant

HER2-Positive Metastatic Breast Cancer Patients Receiving

New therapies in HER2-positive breast cancer: A major step towards

Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic

Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic

IJMS, Free Full-Text

Immunotherapy for HER2-positive breast cancer: recent advances and

Pertuzumab, trastuzumab, and docetaxel for HER2-positive

JCI Insight - Trastuzumab/pertuzumab combination therapy

Epidermal growth factor receptor dimerization status determines

The evolving therapeutic landscape of trastuzumab-drug conjugates

Chau DANG, Macquarie University, Sydney

A randomized, controlled phase II trial of neoadjuvant ado